Treating rectal cancer in patients age 75 and older
Part of Cancer clinical trials.
This trial compares two treatment plans for older adults with locally advanced rectal cancer to see which one works better and is safer. It tests a full course of chemotherapy and radiation before surgery versus a shorter approach.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 75 years or older.
- You have rectal cancer that has not spread to other organs.
- You are well enough to handle daily activities (WHO score 0 or 1).
- Your tumor is at least 5 cm or has grown into deeper layers of the rectal wall.
- You have not had radiation to the pelvic area before.
- You agree not to father a child during treatment and for 6 months after.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two approaches to treating rectal cancer in people age 70 and older who have not yet had surgery. One approach gives chemotherapy and radiation before surgery, and the other adds more chemotherapy after radiation. The goal is to find which plan works better with fewer side effects.
This Phase 2 trial compares a pre-surgery (neoadjuvant) treatment plan versus the standard plan for people with stage II–III rectal cancer. The goal is to see which approach works better and is safe before surgery.
This trial tests whether combining chemotherapy (mFOLFOX6) and a short course of radiation before surgery improves outcomes for people with resectable rectal cancer. The goal is to shrink and control the cancer early and then remove it with curative surgery.
This trial compares a new treatment approach—short-course radiation followed by an immunotherapy drug (PD-1 inhibitor) and chemotherapy (FOLFOX)—to the standard long-course chemoradiation for people with a specific type of advanced rectal cancer that is pMMR/MSS. The goal is to see if the shorter treatment works as well or better.
This trial tests a combination of two types of radiation therapy (external beam and high-dose-rate brachytherapy) for elderly or frail patients with rectal cancer who cannot or choose not to have surgery. The goal is to see if this approach is effective and well-tolerated.
This trial tests a combination of chemotherapy and radiation therapy before surgery for people with mid or low rectal cancer that hasn't spread. The goal is to see if this approach works better than current treatments.
Hear when a new Locally Advanced Rectal Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.